Guangxi Medical University
Clinical trials sponsored by Guangxi Medical University, explained in plain language.
-
New drug combo trial aims to boost fight against aggressive nasal cancer
Disease control CompletedThis study tested whether a new three-drug chemotherapy combination (APF) given before standard radiation and chemo could better control advanced nasopharyngeal cancer. It involved 60 patients in China with newly diagnosed, locally advanced disease that had not spread. The goal w…
Phase: PHASE2 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Four-Pronged attack on tough liver cancer shows promise
Disease control CompletedThis study tested a combination of four treatments for advanced liver cancer that cannot be removed by surgery. The approach involved delivering chemotherapy directly to the liver, blocking the tumor's blood supply, and using two drugs that target the cancer in different ways. Th…
Phase: PHASE2 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated Mar 17, 2026 13:10 UTC